Effect of targeted therapies on pulmonary function in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

bDMARDs and tsDMARDs appear to stabilise pulmonary function in RA-ILD, without significant differences between agents. Further prospective studies integrating PFT and HRCT endpoints are needed to better define their pulmonary safety and long-term effects.